GSE146687 irinotecan 2 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE146687_irinotecan_2_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE146687_irinotecan_2_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE146687_irinotecan_2_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE146687_irinotecan_2_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

RNA, 7SL, cytoplasmic 32, pseudogene

Gene

long intergenic non-protein coding RNA 2097

Gene

ACTR1A pseudogene 1

Gene

RNA, 7SL, cytoplasmic 416, pseudogene

Gene

RNA, 7SL, cytoplasmic 66, pseudogene

Gene

prostaglandin E synthase 3 pseudogene 4

Gene

DENN domain containing 11

Gene

zinc finger with KRAB and SCAN domains 8

Gene

guanylate cyclase 2C

Gene

dickkopf Wnt signaling pathway inhibitor 2

  • Gene

    RNA, 7SL, cytoplasmic 32, pseudogene


  • Gene

    long intergenic non-protein coding RNA 2097


  • Gene

    ACTR1A pseudogene 1


  • Gene

    RNA, 7SL, cytoplasmic 416, pseudogene


  • Gene

    RNA, 7SL, cytoplasmic 66, pseudogene


  • Gene

    prostaglandin E synthase 3 pseudogene 4


  • Gene

    DENN domain containing 11


  • Gene

    zinc finger with KRAB and SCAN domains 8


  • Gene

    guanylate cyclase 2C


  • Gene

    dickkopf Wnt signaling pathway inhibitor 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.